I’m Aware That I’m Rare: Tom Krohn (192)

The phaware® interview

Tom Krohn is the Chief Development Officer at Antidote. In this episode, Tom details a collaboration betweenphaware global association® and Antidote Technologies to accelerate lung disease research. This partnershipprovides pharmaceutical companies with end-to-end clinical…